Page last updated: 2024-11-06

phentolamine and Night Blindness

phentolamine has been researched along with Night Blindness in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Night Blindness: Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pepose, J1
Brigell, M1
Lazar, E1
Heisel, C1
Yousif, J1
Rahmani, K1
Kolli, A1
Hwang, M1
Mitrano, C1
Lazar, A1
Charizanis, K1
Sooch, M1
McDonald, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances[NCT04004507]Phase 224 participants (Actual)Interventional2007-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for phentolamine and Night Blindness

ArticleYear
A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.
    BMC ophthalmology, 2022, Oct-08, Volume: 22, Issue:1

    Topics: Adult; Contrast Sensitivity; Female; Glare; Humans; Hyperemia; Male; Middle Aged; Night Blindness; N

2022